Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

IMA and IMA/albumin levels don't predict alopecia areata severity.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

The study found that white hair in vitiligo has specific patterns and structures, which vary with the stage of the disease and may be similar to another hair condition.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Trichoscopy is a useful non-invasive method for diagnosing different hair loss conditions.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.